0000950170-24-039617.txt : 20240401
0000950170-24-039617.hdr.sgml : 20240401
20240401184651
ACCESSION NUMBER: 0000950170-24-039617
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240401
FILED AS OF DATE: 20240401
DATE AS OF CHANGE: 20240401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jacobson Mark L.
CENTRAL INDEX KEY: 0001805812
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37635
FILM NUMBER: 24811622
MAIL ADDRESS:
STREET 1: 200 BROADWAY
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10038
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axsome Therapeutics, Inc.
CENTRAL INDEX KEY: 0001579428
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 454241907
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
BUSINESS PHONE: (212) 332-3241
MAIL ADDRESS:
STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
4
1
ownership.xml
4
X0508
4
2024-04-01
0001579428
Axsome Therapeutics, Inc.
AXSM
0001805812
Jacobson Mark L.
C/O AXSOME THERAPEUTICS, INC.
ONE WORLD TRADE CENTER, 22ND FLOOR
NEW YORK
NY
10007
false
true
false
false
Chief Operating Officer
true
Common Stock
2024-04-01
4
M
false
24662
1.3
A
24662
D
Common Stock
2024-04-01
4
S
false
24662
77.242
D
0
D
Stock Option (Right to Buy)
1.30
2024-04-01
4
M
false
24662
0.00
D
2014-10-03
2024-04-03
Common Stock
24662
0
D
Represents an exercise of stock options immediately prior to the 10-year expiration date of such options.
Such transaction was pursuant to a pre-approved 10b5-1 plan.
Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
/s/ Mark Jacobson
2024-04-01